San Diego, CA -- (SBWire) -- 11/03/2023 --Certain directors of ImmunityBio, Inc. are under investigation over potential breaches of fiduciary duties.
Investors who are current long term investors in ImmunityBio, Inc. (NASDAQ: IBRX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors NASDAQ: IBRX stocks follows a lawsuit filed against ImmunityBio, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: IBRX stocks, concerns whether certain ImmunityBio, Inc. directors are liable in connection with the allegations made in that lawsuit.
Te plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that ImmunityBio conducted insufficient due diligence to discover, or else did discover and ignored, GMP deficiencies at its third-party CMOs for Anktiva, that one or more of the Company's third-party CMOs for Anktiva did in fact suffer from GMP deficiencies, that the foregoing deficiencies was likely to cause the FDA to reject the Anktiva BLA in its present form, that accordingly, the Company overstated the regulatory approval prospects for the Anktiva BLA, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of ImmunityBio, Inc. (NASDAQ: IBRX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ:IBRX Long Term Investor Alert: Investigation over Potential Wrongdoing at ImmunityBio, Inc.
An investigation on behalf of current long term investors in ImmunityBio, Inc. (NASDAQ:IBRX) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ: IBRX stockholders should contact the Shareholders Foundation.